Difference between revisions of "PSMD6-AS1"

From LncRNAWiki
Jump to: navigation, search
(Diseases)
Line 15: Line 15:
 
===Diseases===
 
===Diseases===
 
Gliomas<ref name="ref1" />.
 
Gliomas<ref name="ref1" />.
 +
 
Papillary Thyroid Cancer<ref name="ref2" />.
 
Papillary Thyroid Cancer<ref name="ref2" />.
  

Revision as of 08:05, 18 July 2017

Annotated Information

Name

PSMD6-AS1:PSMD6 antisense RNA 1

Lnc00462717[1]

Cellular Localization

ENST00462717 is located on chromosome 12 upstream of the MDM2 promoter region[1].

Function

Lnc00462717 overexpression suppresses glioma cell proliferation, survival and migration while knockdown of lnc00462717 has an opposite result.[1].

Regulation

MDM2 expression is inversely regulated by lnc00462717 in glioma[1].

Diseases

Gliomas[1].

Papillary Thyroid Cancer[2].

Labs working on this lncRNA

  • EEG Room, Department of Neurology, Qilu Hospital of Shandong University, Shandong 250012, China
  • Department of Neurology, Qilu Hospital of Shandong University, Shandong 250012, China
  • Department of Medical Insurance Office, Qilu Hospital of Shandong University, Shandong 250012, China[1].
  • Department of Nuclear Medicine, Shanghai Jiao Tong University Affliated Sixth People’s Hospital, Shanghai, China[2].

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Wang A, Meng M, Zhao X, Kong L. Long non-coding RNA ENST00462717 suppresses the proliferation, survival, and migration by inhibiting MDM2/MAPK pathway in glioma. Biochem Biophys Res Commun. 2017 Apr 1;485(2):513-521.
  2. 2.0 2.1 Qiu ZL, Shen CT, Sun ZK, Wei WJ, Zhang XY, Song HJ, Luo QY. Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting 131I Uptake and Mortality in Papillary Thyroid Cancer Patients with Lung Metastases. Cell Physiol Biochem. 2016;40(6):1377-1390.